GlassScriptPhysician profile
Craig A Hoover
NPI 1114905973
$20,098.34
in general payments reported to CMS, 2019-2025
18 companies · $715 in 2025
The $715 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $564 · 2021: $1,213 · 2022: $911 · 2023: $1,170 · 2024: $2,344 · 2025: $715.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,576 · Travel and Lodging: $653.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,576.02 |
| Travel and Lodging | $653.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $7,344.06 | 2019-2022 | |
| Abiomed | $4,082.79 | 2019-2025 | Impella |
| Abbott Laboratories | $2,217.77 | 2019-2024 | Mitraclip |
| Edwards Lifesciences Corporation | $1,844.39 | 2019-2024 | Mitris Resilia Mitral Valve, Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Philips North America LLC | $1,388.97 | 2019-2022 | |
| Medtronic Vascular, INC. | $671.25 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $425.06 | 2019-2021 | |
| Cvrx, INC. | $348.30 | 2020-2024 | Barostim Neo System |
| Zoll Respicardia, INC. | $338.27 | 2021-2023 | Remede System |
| Boston Scientific Corporation | $328.84 | 2020-2025 | General - Balloon Catheters, General - Stents |
| Pfizer INC. | $276.18 | 2019-2022 | |
| Medtronic, INC. | $198.53 | 2021 | |
| Shockwave Medical, INC | $150.29 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Penumbra, INC. | $138.61 | 2024 | Indigo System |
| Saranas, INC. | $130.37 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $128.88 | 2019-2021 | |
| Amgen INC. | $64.04 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $21.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Hoover listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.